Front Matter - The Journal of Bone & Joint Surgery

More documents

Recommendations

Info

Why One Million Gamma Nails Have Been Implanted Worldwide First † Pioneered by visionaries Finest Improved through experience Preferred †† Most trusted and implanted device of its type Surgeons have embraced Stryker’s Gamma technology and have implanted over one million worldwide.* This extraordinary statistic speaks to the trust surgeons across the globe place in Gamma Nails, and to the Gamma Nail innovators who strive for excellence. Nearly two decades ago, Stryker introduced the first † generation of Gamma Nail to the world market. Today, the third generation intramedullary sliding lag screw nail continues to define the industry standard. Gamma Locking Nail System The unmistakable advantages of the Gamma Nail Family • Over 17 years of clinical experience • New smaller implant with streamlined instrumentation • Minimally invasive surgery with the possibility for less bone removal • Three entry options for beginning the procedure • Potential for earlier weight bearing** Stryker is proud to work side-by-side with trauma and orthopaedic surgeons to herald in the future of orthopaedic fracture treatment. To see a Live Gamma3 procedure performed on a cadaver by Drs. Christopher Born, James Maxey and Robert Probe, please visit www.or-live.com/Gamma3/1458 For more information, visit www.stryker.com/gamma or contact your Stryker Trauma Representative. * Includes Gamma, Gamma-Ti, and Gamma3 ** Early weight bearing as appropriate for the patient and determined by the Surgeon. References available upon request. † Based on trademark filing with the United States Patent and Trademark Office, US Registration # 2819616. †† Millennium Research Group, US Markets for Trauma Devices, February 2005, Intramedullary Hip Screw Market. Stryker Orthopaedics 325 Corporate Drive, Mahwah, NJ 07430 www.stryker.com A surgeon is the best person to decide with the patient which treatments and products are right for them. Surgeons must always rely on their own clinical judgment when deciding which treatments and procedures to use with patients. Copyright © 2007 Stryker. All rights reserved. Downloaded From: http://jbjs.org/ on 01/27/2014
Downloaded From: http://jbjs.org/ on 01/27/2014
Page 1 and 2: In a pivotal head-to-head study,* E
Page 3 and 4: Downloaded From: http://jbjs.org/ o
Page 5 and 6: EXOGEN ultrasound treatment has the
Page 9 and 10: NEW Designed by John L. Stanton, MD
Page 11 and 12: The marriage of the Uni and the PFJ
Page 15 and 16: INSTRUCTIONS TO AUTHORS THE JOURNAL
Page 17 and 18: INSTRUCTIONS TO AUTHORS THE JOURNAL
Page 19 and 20: AOA ~ KELLOGG LEADERSHIP SERIES ~ E
Page 21 and 22: PUBLISHED IN TWO VOLUMES AMERICAN V
Page 23 and 24: EDITORIAL STAFF AMERICAN OFFICE 20
Page 25 and 26: For MIS and Navigation Assisted Hip
Page 31 and 32: Experience Reserve your AAOS Annual
Page 33 and 34: Adv 32 JBJS [Br] Abstracts Now Avai
Page 35 and 36: 2006 Corporate Associates Platinum
Page 37 and 38: “ DYONICS ELECTROBLADE Resector m
Page 39 and 40: IMPORTANT SAFETY INFORMATION: *Beca
Page 41 and 42: THROMBIN, TOPICAL U.S.P. (BOVINE OR
Page 43 and 44: The Main Event The comprehensive me
Page 47 and 48: ® ® ® ® ® ®
Page 51: Features of BONE FOAM • Radioluce
Page 55 and 56: T-Pin for Distal Radius Fracture Fi
Page 57 and 58: UNIQUE NATIONAL HCPCS CODE Q4084 BR
Page 63 and 64: FRAGMIN (dalteparin sodium injectio
Page 67 and 68: moving beyond simple wear reduction
Page 71: See brief summary on page 110 Downl

Front Matter - The Journal of Bone & Joint Surgery

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?